Robert J. Shovlin Neogenomics Inc (NEO) insider trading activity

NEO Quotes by TradingView

Robert J. Shovlin is President, Clinical Services of NEOGENOMICS INC. Currently has a direct ownership of 150,101 shares of NEO, which is worth approximately $2.76 Million. The most recent transaction as insider was on May 25, 2021, when has been sold 130,604 shares (Common Stock) at a price of $39.31 per share, resulting in proceeds of $5,134,043. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K
0% 3M change
0% 12M change
Total Value Held $2.76 Million

ROBERT J. SHOVLIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 25 2021
SELL
Open market or private sale
$5,134,043 $39.31 p/Share
130,604 Reduced 46.53%
150,101 Common Stock
May 25 2021
BUY
Exercise of conversion of derivative security
$2,367,767 $18.65 p/Share
126,958 Added 31.14%
280,705 Common Stock
Mar 02 2021
SELL
Payment of exercise price or tax liability
-
608 Reduced 0.41%
146,920 Common Stock
Mar 02 2021
BUY
Grant, award, or other acquisition
-
6,827 Added 4.25%
153,747 Common Stock
Mar 01 2021
SELL
Payment of exercise price or tax liability
-
742 Reduced 0.5%
147,528 Common Stock
RJS

Robert J. Shovlin

President, Clinical Services
Fort Myers, FL

Track Institutional and Insider Activities on NEO

Follow NEOGENOMICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NEO shares.

Notify only if

Insider Trading

Get notified when an Neogenomics Inc insider buys or sells NEO shares.

Notify only if

News

Receive news related to NEOGENOMICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NEO